Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
10
11
12
13
14
15
16
19
11:00 AM - Charmalot 2025
20
21
22
23
24
25
26
27
29
1
2
3
4
5
Oracle Health and Life Sciences Summit 2025
2025-09-09 - 2025-09-11    
12:00 am
The largest gathering of Oracle Health (Formerly Cerner) users. It seems like Oracle Health has learned that it’s not enough for healthcare users to be [...]
MEDITECH Live 2025
2025-09-17 - 2025-09-19    
8:00 am - 4:30 pm
This is the MEDITECH user conference hosted at the amazing MEDITECH conference venue in Foxborough (just outside Boston). We’ll be covering all of the latest [...]
AI Leadership Strategy Summit
2025-09-18 - 2025-09-19    
12:00 am
AI is reshaping healthcare, but for executive leaders, adoption is only part of the equation. Success also requires making informed investments, establishing strong governance, and [...]
OMD Educates: Digital Health Conference 2025
2025-09-18 - 2025-09-19    
7:00 am - 5:00 pm
Why Attend? This is a one-of-a-kind opportunity to get tips from experts and colleagues on how to use your EMR and other innovative health technology [...]
Charmalot 2025
2025-09-19 - 2025-09-21    
11:00 am - 9:00 pm
This is the CharmHealth annual user conference which also includes the CharmHealth Innovation Challenge. We enjoyed the event last year and we’re excited to be [...]
Civitas 2025 Annual Conference
2025-09-28 - 2025-09-30    
8:00 am
Civitas Networks for Health 2025 Annual Conference: From Data to Doing Civitas’ Annual Conference convenes hundreds of industry leaders, decision-makers, and innovators to explore interoperability, [...]
TigerConnect + eVideon Unite Healthcare Communications
2025-09-30    
10:00 am
TigerConnect’s acquisition of eVideon represents a significant step forward in our mission to unify healthcare communications. By combining smart room technology with advanced clinical collaboration [...]
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
Events on 2025-09-09
Events on 2025-09-17
MEDITECH Live 2025
17 Sep 25
MA
Events on 2025-09-18
OMD Educates: Digital Health Conference 2025
18 Sep 25
Toronto Congress Centre
Events on 2025-09-19
Charmalot 2025
19 Sep 25
CA
Events on 2025-09-28
Civitas 2025 Annual Conference
28 Sep 25
California
Events on 2025-10-05

Events

Latest News Press Releases

Navigant Consulting, Inc. (NCI) Announces Acquisition of McKinnis Consulting Services

it staffing

Navigant (NYSE: NCI) announced it acquired McKinnis Consulting Services, a firm that provides revenue cycle assessment, strategy, and optimization assistance for healthcare providers.

The addition of more than 70 McKinnis consultants complements Navigant’s existing revenue cycle management (RCM) capabilities as the healthcare landscape continues to evolve. The acquisition further enhances Navigant’s position as a leading provider of end-to-end RCM services, including assessment, electronic health records (EHR) risk mitigation, and optimization services.

“McKinnis is a market leader in revenue cycle management services, and now in combination with the breadth and depth of Navigant’s healthcare team, will be able to provide clients with an even richer set of offerings to optimize their operations,” said Julie Howard, Chairman and Chief Executive Officer, Navigant.

Based in Chicago, McKinnis is a market leader and KLAS top-rated firm that delivers targeted strategies across all major EHR systems, assisting healthcare providers in achieving sustainable revenue cycle improvement through an integrated approach involving technology optimization and operational best practices. McKinnis’ clients range across a variety of provider types, including academic medical centers, multi-hospital health systems, physician groups, and community hospitals among others. McKinnis’ leadership team includes its three founders, James McHugh, Timothy Kinney, and John Morris, who will become part of the Navigant revenue cycle leadership team.

“The McKinnis transaction is purpose-driven to expand our RCM capabilities at a time when health system margins are under greater scrutiny. McKinnis’ operational and technical expertise, streamlined methodologies, and outcome-based processes are best in class,” said David Zito, Managing Director and Navigant healthcare segment leader. “The McKinnis professionals, which include the firm’s founders, further complement our ability to help clients navigate through the disruptions in the healthcare sector.”

“Recent legislation and market drivers have bolstered spending in the healthcare industry and increased demand for EHR optimization on the clinical side. Our EHR risk mitigation and optimization expertise, combined with Navigant’s clinical expertise, will create timely solutions for healthcare organizations. We are excited to join forces with Navigant to design innovative offerings that help our clients realize their goals,” said James McHugh, Managing Director, McKinnis.

Transaction Overview

Under the terms of the purchase agreement, Navigant paid approximately $49 million in cash and $3 million in Navigant common stock at closing, and may pay up to an additional $10 million to the sellers based on the acquired company’s achievement of certain post-closing performance targets.

Provides Perspective on 2015 Results and 2016 Financial Outlook

“The addition of McKinnis is another important step in the execution of our strategy to grow our premier healthcare business, both organically and with highly profitable investments,” said Howard. “With anticipated contributions from McKinnis in 2016, the Healthcare segment is expected to deliver significant year over year top line growth, the majority of which we expect to be organic.”

Howard further commented, “We anticipate that, on a total company basis, full year 2015 financial results will meet our prior estimates and as we look to 2016, we believe the demand environment for many of our practice areas throughout the firm will remain positive. We anticipate mostly organic RBR and adjusted EBITDA growth in 2016 in excess of historical trends, with higher adjusted EBITDA margins and adjusted earnings per share as compared to full year 2015. We look forward to discussing our 2015 results and 2016 financial outlook in more detail during our annual earnings call in February.”

Source